8-K: Cycurion Secures $6M Private Placement for Growth

Cycurion, Inc. announced the closing of a $6 million private placement with a single institutional investor to fund its inorganic growth strategy and strengthen its AI-powered cybersecurity and IT solutions.

Summary

• Cycurion, Inc. completed a private placement raising approximately $6 million in gross proceeds.
• The placement involved the sale of 1,657,460 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 3,314,920 shares of common stock.
• The effective combined purchase price was $3.62 per share and common warrant.
• The pre-funded warrants have a nominal exercise price of $0.0001 per share and are exercisable from December 5, 2025.
• The common warrants have an exercise price of $3.62 per share, will be exercisable immediately following receipt of stockholder approval, and will expire five years from their initial exercise date.
• The company intends to use the net proceeds for working capital and general corporate purposes, specifically to accelerate inorganic growth, execute on backlog, and enhance AI-powered cybersecurity and government IT solutions.
• A.G.P./Alliance Global Partners acted as the sole placement agent, receiving a 10.0% cash fee of gross proceeds ($600,000), a $500,000 cash fee for a prior transaction, and up to $60,000 for legal expenses.
• The company is required to file a registration statement for the resale of the shares and warrant shares within 20 calendar days of closing and aim for effectiveness within 60 days (or 90 days if SEC review).
• Stockholder approval is required for the issuance of the common warrants and underlying shares, with a meeting to be held within 90 days of closing, and every 90 days thereafter until approval is obtained.
• Executive officers and directors are subject to a 90-day lock-up period following the registration statement's effective date.

Sentiment

Score: 6

Explanation: The capital raise provides necessary funding for strategic initiatives and working capital, which is positive. However, the significant dilution, high placement agent fees, and the contingency of stockholder approval for warrants introduce notable concerns, balancing the overall sentiment to moderately positive.

Positives

• Secured $6 million in gross proceeds from a single institutional investor, indicating investor confidence.
• Capital will accelerate inorganic growth strategy and fuel execution on existing backlog.
• Strengthens the company's push to lead in AI-powered cybersecurity and mission-critical government IT solutions.
• The placement was priced 'at-the-market' under Nasdaq rules, which can be seen as a positive for pricing efficiency.

Negatives

• Significant dilution potential from the issuance of 1,657,460 shares (or pre-funded warrants) and warrants for 3,314,920 shares.
• High placement agent fees: 10.0% of gross proceeds ($600,000) plus an additional $500,000 cash fee for a prior transaction, and up to $60,000 for legal expenses, totaling over $1.1 million, which is a substantial portion of the $6 million raise.
• Requirement for stockholder approval for common warrants introduces a potential delay or uncertainty.
• The common stock is currently subject to delisting by the Trading Market, as acknowledged in the filing.

Risks

• Dilution Risk: The issuance of new shares and warrants could dilute the ownership of existing shareholders.
• Stockholder Approval Risk: Failure to obtain stockholder approval for the common warrants could impact their exercisability and the company's ability to fully realize the capital structure intended by the offering.
• Registration Statement Effectiveness Risk: The company's ability to keep the registration statement effective is crucial for the resale of securities by the investor; failure could lead to liquidated damages.
• Market Price Volatility: Future open market or derivative transactions by the purchaser, including short sales, may negatively impact the market price of the company's publicly-traded securities.
• Delisting Risk: The common stock is currently subject to delisting by the Trading Market.
• Regulatory Compliance Risk: Failure to comply with SEC and Trading Market rules regarding filings and listing requirements could have adverse effects.

Future Outlook

Cycurion anticipates using the capital to accelerate its inorganic growth strategy, continue executing on its backlog, and strengthen its position in AI-powered cybersecurity and government IT solutions. The company also expects to file a registration statement for resale of the securities and seek stockholder approval for the common warrants.

Management Comments

• "We're thrilled to enter into this $6 million at-the-market placement with a single institutional investor."
• "This capital accelerates our inorganic growth strategy, fuels continued execution on our backlog and strengthens our push to lead in AI-powered cybersecurity and mission-critical government IT solutions."

Industry Context

This capital raise positions Cycurion to further invest in the growing cybersecurity and government IT sectors, particularly in AI-enhanced solutions. The focus on inorganic growth suggests a strategy to acquire complementary businesses or technologies to expand market share and capabilities in a competitive landscape driven by increasing digital threats and government modernization initiatives.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for significant dilution due to the issuance of new shares and warrants. Existing shareholders will also bear the cost of placement agent fees.
• Institutional Investor (Armistice Capital Master Fund Ltd.): Gains a substantial equity position and potential upside through warrants, with protective provisions like beneficial ownership limitations and registration rights.
• Employees/Management: Executive officers and directors are subject to lock-up agreements, aligning their interests with the company's post-offering performance.

Next Steps

• File a registration statement with the SEC covering the resale of the shares and warrant shares within 20 calendar days following the closing.
• Use commercially reasonable efforts to cause the registration statement to be declared effective by the SEC within 60 days (or 90 days if reviewed).
• Hold a meeting of stockholders on or prior to 90 days following the closing to obtain approval for the issuance of the common warrants and underlying shares.
• If stockholder approval is not obtained at the first meeting, call a meeting every 90 days thereafter until approval is received or the warrants are no longer outstanding.
• Maintain listing or quotation of common stock on the Trading Market and apply to list all new shares and warrant shares.

Key Dates

Recommendation

While the capital raise provides essential funding for Cycurion's strategic growth in cybersecurity and AI, the significant dilution from the issuance of shares and warrants, coupled with substantial placement agent fees, presents a mixed financial picture. The requirement for stockholder approval for the common warrants adds a layer of uncertainty. The company's stated use of proceeds for inorganic growth and backlog execution is positive, but the current delisting risk for the common stock is a concern. Investors should hold to monitor the execution of the growth strategy, the impact of dilution, and the resolution of the stockholder approval and listing issues.

Keywords

Cycurion, CYCU, Private Placement, Equity Financing, Warrants, Pre-Funded Warrants, Cybersecurity, Government IT, AI, Capital Raise, SEC Filing, Stock Dilution, Institutional Investor